Adage Capital Partners’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,700,756
| Closed | -$3.83M | – | 912 |
|
|
2025
Q1 | $3.83M | Sell |
1,700,756
-7,014,257
| -80% | -$15.8M | 0.01% | 725 |
|
|
2024
Q4 | $30.5M | Sell |
8,715,013
-1,000,000
| -10% | -$3.5M | 0.05% | 322 |
|
|
2024
Q3 | $39.9M | Sell |
9,715,013
-2,076,297
| -18% | -$8.53M | 0.07% | 279 |
|
|
2024
Q2 | $42.4M | Buy |
11,791,310
+2,462,571
| +26% | +$8.87M | 0.08% | 243 |
|
|
2024
Q1 | $30.8M | Buy |
9,328,739
+6,678,739
| +252% | +$22M | 0.06% | 347 |
|
|
2023
Q4 | $6.12M | Buy |
2,650,000
+1,850,000
| +231% | +$4.27M | 0.01% | 662 |
|
|
2023
Q3 | $1.03M | Buy |
+800,000
| New | +$1.03M | ﹤0.01% | 763 |
|
|
2022
Q1 | – | Sell |
-1,000,000
| Closed | -$1.6M | – | 1113 |
|
|
2021
Q4 | $1.6M | Hold |
1,000,000
| – | – | ﹤0.01% | 879 |
|
|
2021
Q3 | $2.42M | Buy |
+1,000,000
| New | +$2.42M | ﹤0.01% | 888 |
|